Journal profile · ONCOLOGY
ESMO Real World Data and Digital Oncology
ISSN 2949-8201
ESMO Real World Data and Digital Oncology: impact factor 2.6 (journal website); fully open access; APC about USD 3,480; review about 110 days (submission to acceptance, publisher); 460 articles in 2025; indexed in ESCI.
Scope
Aims, scope and focus
By OpenAlex counts of its recent articles, ESMO Real World Data and Digital Oncology's largest topics are Radiomics and Machine Learning in Medical Imaging, Artificial Intelligence in Healthcare and Education and AI in cancer detection, together about 37.4% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
ESMO Real-World Data and Digital Oncology, the journal of the European Society for Medical Oncology, is dedicated to publishing high-quality data science and educational content on the transformation of oncology care with real-world evidence, digital technologies and artificial intelligence-based tools that physicians can trust and understand.The journal will publish innovative research that provides actionable insights from real-world data sources and digital devices, such as generalizable observational and health services research, clinical informatics solutions, artificial intelligence-powered diagnostics or decision support systems and direct-to-patient mobile applications.Main focuses of interest include disease characterization, rare and under-represented populations in clinical trials, head-to-head comparative effectiveness, unmet needs and gaps in access or care delivery, resource utilization and heath economics, post-marketing treatment optimization and tolerability and patients' outcomes and preferences. In addition, studies that evaluate the net benefit of incorporating artificial intelligence applications in clinical practice, or explore how the human aspect of medicine, relations between patient and physician, may be affected by the increasing use of technology in routine practice.With an international editorial board of experts and key opinion leaders, the journal will support multiple stakeholders as they engage with digital solutions and information systems to solve complex cancer problems. Providing essential reading for all stakeholders we will publish original research, reviews, editorials, perspectives, correspondence, and news.The journal will provide balanced implementation guidance, training, and resources to ensure appropriate use of real-world data and digital technologies, at the highest methodological standards. ESMO Real-World Data and Digital Oncology aims to operate a fast submission process with continuous publication online, to ensure that timely, up-to-date research is available worldwide and adheres to a rigorous and transparent peer review process.
From the journal's Aims & Scope
Research area (LetPub): ONCOLOGY
Editor-in-chief Rodrigo DienstmannPublisher website
Editorial board by country: none in mainland China; most named France 7, Italy 6, Spain 6, United States 3, Netherlands 3 (37 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Radiomics and Machine Learning in Medical ImagingMedicine15.4%
- Artificial Intelligence in Healthcare and EducationMedicine13.8%
- AI in cancer detectionComputer Science8.3%
- Machine Learning in HealthcareComputer Science7.4%
- Cancer Genomics and DiagnosticsBiochemistry, Genetics and Molecular Biology5.7%
- Cancer Immunotherapy and BiomarkersMedicine5.2%
- Cancer survivorship and careMedicine3.4%
- Breast Cancer Treatment StudiesBiochemistry, Genetics and Molecular Biology3.2%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
ScopusPubMedPublisher website
Other: Crossref
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher)
- 2.6Publisher website ·
- h-index
- 11OpenAlex ·
- i10-index
- 13OpenAlex ·
- 2-year mean citedness
- 0.82OpenAlex ·
- Self-citation rate
- 3.8%LetPub ·
- Share of gold OA articles
- 99.23%LetPub ·
Volume
- Articles per year
- 80LetPub ·
Articles by year OpenAlex count · 641 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 110 | 110 | 56 |
| 2025 | 460 | 460 | 166 |
| 2024 | 61 | 61 | 295 |
| 2023 | 10 | 10 | 42 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
Too few articlesOnly 1 articles from the last 24 months carry both submission and acceptance dates, too few for a median
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Figures by source
- Submission to acceptance
- 110 daysPublisher website ·
- Submission to publication (journal-reported)
- about 20 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 3,480 | Yes | CC BY-NC-ND | |
| OpenAlex | USD 3,170 / EUR 2,890 / GBP 2,540 / JPY 393,180 | — | — | |
| Publisher website | USD 3,480 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted15, with length limits
- editorialOriginal Articles (maximum of 3,500 words from the beginning of the Introduction to the end of the Discussion)Original articles should describe original researc…main text ≤ 1,500 words
- editorialsEditorials (maximum 1,500 words)Length not stated
- letters to the editorLetters to the Editor (maximum 500 words)Length not stated
- narrative reviewOriginal Articles (maximum of 3,500 words from the beginning of the Introduction to the end of the Discussion)Original articles should describe original researc…Length not stated
- newsNews News items will highlight news and events of relevance to the journal's readership.Length not stated
- original articleOriginal Articles (maximum of 3,500 words from the beginning of the Introduction to the end of the Discussion)Original articles should describe original researc…main text ≤ 3,500 words
- original articlesOriginal Articles (maximum of 3,500 words from the beginning of the Introduction to the end of the Discussion)Length not stated
- original researchOriginal Articles (maximum of 3,500 words from the beginning of the Introduction to the end of the Discussion)Original articles should describe original researc…Length not stated
- perspectiveOriginal Articles (maximum of 3,500 words from the beginning of the Introduction to the end of the Discussion)Original articles should describe original researc…main text ≤ 1,500 words
- perspectivesPerspectives (maximum of 1,500 words)Length not stated
- reviewOriginal Articles (maximum of 3,500 words from the beginning of the Introduction to the end of the Discussion)Original articles should describe original researc…Length not stated
- review articleOriginal Articles (maximum of 3,500 words from the beginning of the Introduction to the end of the Discussion)Original articles should describe original researc…main text ≤ 4,000 words
- review articlesReview Articles (maximum 4,000 words)Length not stated
- short communicationOriginal Articles (maximum of 3,500 words from the beginning of the Introduction to the end of the Discussion)Original articles should describe original researc…main text ≤ 2,000 words
- short communication articlesShort Communication Articles (maximum of 2,000 words from the beginning of the Introduction to the end of the Discussion)Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Data availability, Publication ethics, License & copyright, Open access, Peer review, Preprints
- AI use Declaration of generative AI in scientific writing
The below guidance only refers to the writing process, and not to the use of AI tools to analyse and draw insights from data as part of the research process.Where authors use generative artificial intelligence (AI) and AI-assisted technologies in the writing process, authors should only use these technologies to improve readability and language. AI and AI-assisted technologies should not be used t…
Source ↗Publisher website ·- Authorship Authorship
All authors should have made substantial contributions to all of the following: (1) the conception and design of the study, or acquisition of data, or analysis and interpretation of data, (2) drafting the article or revising it critically for important intellectual content, (3) final approval of the version to be submitted.
Source ↗Publisher website ·- Conflicts of interest Declaration of Potential Conflicts of Interest
A competing interests statement is required, even if there are no competing interests to declare. Model summary
Any financial interests or connections, direct or indirect, or other situations that might raise the question of bias in the work reported or the conclusions, implications or opinions stated - including pertinent commercial or other sources of funding for the individual author(s) or for the associated department(s) or organization(s), personal relationships, or direct academic competition - should…
Source ↗Publisher website ·- Data availability
Real-world data studies should follow ESMO-GROW reporting guidance; GROW checklist and flowchart requested at submission. Model summary
It is recommended that real-world data studies be reported according to the ESMO-Guidance for Reporting Oncology real-World evidence (GROW). At manuscript submission, authors are requested to provide the GROW checklist accompanied by a flowchart.
Source ↗Publisher website ·- Publication ethics
Human subjects research must be carried out in accordance with the Declaration of Helsinki. Model summary
If the work involves the use of human subjects, the author should ensure that the work described has been carried out in accordance with The Code of Ethics of the World Medical Association (Declaration of Helsinki) for experiments involving humans.
Source ↗Publisher website ·- License & copyright Copyright
Authors complete a License Agreement upon acceptance; permitted third party reuse of open access articles is determined by the author's choice of user license. Model summary
Upon acceptance of an article, authors will be asked to complete a 'License Agreement' (see more information on this). Permitted third party reuse of open access articles is determined by the author's choice of user license.Author rightsAs an author you (or your employer or institution) have certain rights to reuse your work. More information.
Source ↗Publisher website ·- Open access Open Access
Please visit our Open Access page for more information about open access publishing in this journal.
Source ↗Publisher website ·- Peer review Peer Review
This journal operates a single anonymized review process. All contributions will be initially assessed by the editor for suitability for the journal. Papers deemed suitable are then typically sent to a minimum of two independent expert reviewers to assess the scientific quality of the paper. The Editor is responsible for the final decision regarding acceptance or rejection of articles. The Editor'…
Source ↗Publisher website ·- Preprints Preprints
Preprints can be shared anywhere at any time; sharing on a preprint server will not count as prior publication. Model summary
Please note that preprints can be shared anywhere at any time, in line with Elsevier's sharing policy. Sharing your preprints e.g. on a preprint server will not count as prior publication (see 'Multiple, redundant or concurrent publication' for more information).
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- ISSN
- 2949-8201
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗Publisher website
- Author guidelines ↗DOAJ
- Aims & Scope ↗DOAJ
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗DOAJ
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about ESMO Real World Data and Digital Oncology
What is the impact factor of ESMO Real World Data and Digital Oncology?
The journal's website gives an impact factor of 2.6; this is the journal's own figure, as LetPub lists none for it; h-index 11.
How long does peer review take at ESMO Real World Data and Digital Oncology?
The publisher reports about 110 days (submission to acceptance). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of ESMO Real World Data and Digital Oncology based?
Of the 37 board members whose country the journal's board page names, none are in mainland China; the countries named most often are France (7), Italy (6) and Spain (6). Counted from the institutions listed on the board page; for reference only.
Which databases index ESMO Real World Data and Digital Oncology?
According to LetPub and DOAJ records, ESMO Real World Data and Digital Oncology is indexed in ESCI and DOAJ. The journal's website also lists Scopus and PubMed; that list has not been checked against each database.
Is ESMO Real World Data and Digital Oncology open access, and what is the APC?
ESMO Real World Data and Digital Oncology is a fully open-access journal. APC about USD 3,480.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-30). Last updated: .